Abstract
BACKGROUND: Core Needle Biopsy involves introducing large hollow needle through the skin to collect a tissue for investigation. It’s become a well-established method as the standard sampling procedure. It’s a relatively safe, minimal invasive procedure with diagnostic accuracy comparable to open surgical biopsy. AIM OF STUDY: Assess the accuracy and safety of core needle biopsy in diagnosis of renal and suprarenal tumors. METHODS: This is a prospective interventional study. Core needle biopsy was done for 42 patients; 38 patients were included. Biopsy done by activation of needle biopsy device that introduced into the tumor under ultrasound guidance and collection of sample. RESULTS: Wilms tumor was positive in 71.1 % (n=27), 23.6 % (n=9) were neuroblastoma and 5.3 % (n=2) were non-conclusive. Only 18.4% (n=7) developed hematuria while intra-abdominal bleeding was not observed in any patient. For Wilms tumor the sensitivity is 93.1 % and the specificity is 100 % and diagnostic accuracy is 94.7 %. The sensitivity, specificity and diagnostic accuracy for neuroblastoma are 100 %. CONCLUSION: It is a simple, safe and efficient method for diagnosing renal and suprarenal tumors, complications occur infrequent, and most are easily treated or self-limiting.
Recommended Citation
Alkhatib, Yasir Noman and Khalaf, Ahmed.
(2021)
"Role of Ultrasound Guided Core Needle Biopsy in Diagnosis of Pediatric Renal and suprarenal Tumors,"
Iraqi Postgraduate Medical Journal: Vol. 21:
Iss.
3, Article 2.
DOI: 10.52573/ipmj.2021.175759
Available at:
https://ipmj.researchcommons.org/journal/vol21/iss3/2
DOI
10.52573/ipmj.2021.175759